Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |